{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T05:38:41Z","timestamp":1790487521438,"version":"4.1.0"},"reference-count":137,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,22]],"date-time":"2026-03-22T00:00:00Z","timestamp":1774137600000},"content-version":"am","delay-in-days":325,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["20cm0106306h0005"],"award-info":[{"award-number":["20cm0106306h0005"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["21am0401003h0003"],"award-info":[{"award-number":["21am0401003h0003"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["24fk0108629h0003"],"award-info":[{"award-number":["24fk0108629h0003"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["20fk0108088h0002"],"award-info":[{"award-number":["20fk0108088h0002"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["23K15303"],"award-info":[{"award-number":["23K15303"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["23H02936"],"award-info":[{"award-number":["23H02936"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019356","name":"SGH Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019356","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.leukres.2025.107680","type":"journal-article","created":{"date-parts":[[2025,3,16]],"date-time":"2025-03-16T02:36:20Z","timestamp":1742092580000},"page":"107680","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Stratagems of HTLV-1 for persistent infection and the resultant oncogenesis: Immune evasion and clonal expansion"],"prefix":"10.1016","volume":"152","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1272-3738","authenticated-orcid":false,"given":"Takafumi","family":"Shichijo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7939-2080","authenticated-orcid":false,"given":"Jun-ichirou","family":"Yasunaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2025.107680_bib1","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/nrc2111","article-title":"Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation","volume":"7","author":"Matsuoka","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.leukres.2025.107680_bib2","doi-asserted-by":"crossref","first-page":"e517","DOI":"10.1016\/S1470-2045(14)70202-5","article-title":"Human T-cell leukaemia virus type I and adult T-cell leukaemia-lymphoma","volume":"15","author":"Ishitsuka","year":"2014","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.leukres.2025.107680_bib3","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1182\/blood.V50.3.481.481","article-title":"Adult T-cell leukemia: clinical and hematologic features of 16 cases","volume":"50","author":"Uchiyama","year":"1977","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2025.107680_bib4","doi-asserted-by":"crossref","DOI":"10.1186\/1742-4690-2-16","article-title":"Discovery of adult T-cell leukemia","volume":"2","author":"Takatsuki","year":"2005","journal-title":"Retrovirology"},{"key":"10.1016\/j.leukres.2025.107680_bib5","doi-asserted-by":"crossref","first-page":"7415","DOI":"10.1073\/pnas.77.12.7415","article-title":"Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma","volume":"77","author":"Poiesz","year":"1980","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.leukres.2025.107680_bib6","doi-asserted-by":"crossref","DOI":"10.1186\/1742-4690-2-17","article-title":"The discovery of the first human retrovirus: HTLV-1 and HTLV-2","volume":"2","author":"Gallo","year":"2005","journal-title":"Retrovirology"},{"key":"10.1016\/j.leukres.2025.107680_bib7","doi-asserted-by":"crossref","first-page":"6476","DOI":"10.1073\/pnas.78.10.6476","article-title":"Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera","volume":"78","author":"Hinuma","year":"1981","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.leukres.2025.107680_bib8","doi-asserted-by":"crossref","first-page":"5952","DOI":"10.1038\/sj.onc.1208969","article-title":"Activation of NF-\u03baB by HTLV-I and implications for cell transformation","volume":"24","author":"Sun","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.leukres.2025.107680_bib9","doi-asserted-by":"crossref","DOI":"10.1186\/s12977-020-0511-0","article-title":"HTLV-1 bZIP factor: the key viral gene for pathogenesis","volume":"17","author":"Matsuoka","year":"2020","journal-title":"Retrovirology"},{"key":"10.1016\/j.leukres.2025.107680_bib10","first-page":"2299","article-title":"HTLV-1 persistence and the oncogenesis of adult T cell leukemia\/lymphoma","volume":"141","author":"Bangham","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2025.107680_bib11","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1007\/s12185-023-03547-5","article-title":"Viral, genetic, and immune factors in the oncogenesis of adult T-cell leukemia\/lymphoma","volume":"117","author":"Yasunaga","year":"2023","journal-title":"Int J. Hematol."},{"key":"10.1016\/j.leukres.2025.107680_bib12","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1365-2141.1991.tb08051.x","article-title":"Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87)","volume":"79","author":"Shimoyama","year":"1991","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.leukres.2025.107680_bib13","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0145-2126(93)90061-O","article-title":"Characteristics of chemotherapy-induced clinical remission in long survivors with aggressive adult T-cell leukemia\/lymphoma","volume":"17","author":"Tsukasaki","year":"1993","journal-title":"Leuk. Res"},{"key":"10.1016\/j.leukres.2025.107680_bib14","doi-asserted-by":"crossref","first-page":"5458","DOI":"10.1200\/JCO.2007.11.9958","article-title":"VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study JCOG9801","volume":"25","author":"Tsukasaki","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.leukres.2025.107680_bib15","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1200\/JCO.2008.18.2428","article-title":"Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: a proposal from an international consensus meeting","volume":"27","author":"Tsukasaki","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.leukres.2025.107680_bib16","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1200\/JCO.18.00501","article-title":"Revised adult T-cell leukemia-lymphoma international consensus meeting report","volume":"37","author":"Cook","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.leukres.2025.107680_bib17","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1182\/blood.2019004045","article-title":"How I treat adult T-cell leukemia\/lymphoma","volume":"137","author":"Cook","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2025.107680_bib18","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1053\/j.seminhematol.2021.02.005","article-title":"Diagnosis and management of adult T-cell leukemia\/lymphoma","volume":"58","author":"Ishitsuka","year":"2021","journal-title":"Semin Hematol."},{"key":"10.1016\/j.leukres.2025.107680_bib19","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1093\/jjco\/hyad108","article-title":"An update on the developments in the treatment of adult T-cell leukemia-lymphoma: current knowledge and future perspective","volume":"53","author":"Makiyama","year":"2023","journal-title":"Jpn J. Clin. Oncol."},{"key":"10.1016\/j.leukres.2025.107680_bib20","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1007\/s12185-023-03572-4","article-title":"Current and emerging therapeutic strategies in adult T-cell leukemia-lymphoma","volume":"117","author":"Katsuya","year":"2023","journal-title":"Int J. Hematol."},{"key":"10.1016\/j.leukres.2025.107680_bib21","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/sj.bmt.1702731","article-title":"Improved outcome of adult T cell leukemia\/lymphoma with allogeneic hematopoietic stem cell transplantation","volume":"27","author":"Utsunomiya","year":"2001","journal-title":"Bone Marrow Transpl."},{"key":"10.1016\/j.leukres.2025.107680_bib22","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/bmt.2015.265","article-title":"Early application of related SCT might improve clinical outcome in adult T-cell leukemia\/lymphoma","volume":"51","author":"Fuji","year":"2016","journal-title":"Bone Marrow Transpl."},{"key":"10.1016\/j.leukres.2025.107680_bib23","doi-asserted-by":"crossref","first-page":"3426","DOI":"10.1200\/JCO.2016.67.8250","article-title":"Pretransplantation anti-CCR4 antibody mogamulizumab against adult T-cell leukemia\/lymphoma is associated with significantly increased risks of severe and corticosteroid-refractory graft-versus-host disease, nonrelapse mortality, and overall mortality","volume":"34","author":"Fuji","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.leukres.2025.107680_bib24","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.3324\/haematol.2017.164996","article-title":"Development of a modified prognostic index for patients with aggressive adult T-cell leukemia-lymphoma aged 70 years or younger: possible risk-adapted management strategies including allogeneic transplantation","volume":"102","author":"Fuji","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2025.107680_bib25","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.bbmt.2017.11.005","article-title":"Risk assessment in adult T cell leukemia\/lymphoma treated with allogeneic hematopoietic stem cell transplantation","volume":"24","author":"Yoshimitsu","year":"2018","journal-title":"Biol. Blood Marrow Transpl."},{"key":"10.1016\/j.leukres.2025.107680_bib26","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/s41409-018-0139-z","article-title":"Prognostic importance of pretransplant disease status for posttransplant outcomes in patients with adult T cell leukemia\/lymphoma","volume":"53","author":"Inoue","year":"2018","journal-title":"Bone Marrow Transpl."},{"key":"10.1016\/j.leukres.2025.107680_bib27","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.3389\/fmicb.2019.02235","article-title":"Progress in allogeneic hematopoietic cell transplantation in adult T-cell leukemia-lymphoma","volume":"10","author":"Utsunomiya","year":"2019","journal-title":"Front Microbiol"},{"key":"10.1016\/j.leukres.2025.107680_bib28","doi-asserted-by":"crossref","first-page":"4156","DOI":"10.1182\/bloodadvances.2021004932","article-title":"Improved survival of patients with aggressive ATL by increased use of allo-HCT: a prospective observational study","volume":"5","author":"Ito","year":"2021","journal-title":"Blood Adv."},{"key":"10.1016\/j.leukres.2025.107680_bib29","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1200\/JCO.2011.37.3472","article-title":"Defucosylated anti-CCR4 monoclonal antibody (KW-0761) for relapsed adult T-cell leukemia-lymphoma: a multicenter phase II study","volume":"30","author":"Ishida","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.leukres.2025.107680_bib30","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/bjh.13338","article-title":"Dose-intensified chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T-cell leukaemia-lymphoma: a randomized phase II study","volume":"169","author":"Ishida","year":"2015","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.leukres.2025.107680_bib31","doi-asserted-by":"crossref","first-page":"4086","DOI":"10.1200\/JCO.2016.67.7732","article-title":"Multicenter phase II study of lenalidomide in relapsed or recurrent adult T-cell leukemia\/lymphoma: ATLL-002","volume":"34","author":"Ishida","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.leukres.2025.107680_bib32","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1111\/bjh.18281","article-title":"Beneficial impact of first-line mogamulizumab-containing chemotherapy in adult T-cell leukaemia-lymphoma","volume":"198","author":"Shichijo","year":"2022","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.leukres.2025.107680_bib33","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0140-6736(18)32984-2","article-title":"Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial","volume":"393","author":"Horwitz","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.leukres.2025.107680_bib34","first-page":"1","article-title":"Oral histone deacetylase inhibitor tucidinostat (HBI-8000) in patients with relapsed or refractory adult T-cell leukemia\/lymphoma: Phase IIb results","volume":"00","author":"Utsunomiya","year":"2022","journal-title":"Cancer Sci."},{"key":"10.1016\/j.leukres.2025.107680_bib35","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1016\/j.celrep.2019.10.083","article-title":"Targeting excessive EZH1 and EZH2 activities for abnormal histone methylation and transcription network in malignant lymphomas","volume":"29","author":"Yamagishi","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.leukres.2025.107680_bib36","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1182\/blood.2022016862","article-title":"An open-label, single-arm phase 2 trial of valemetostat for relapsed or refractory adult T-cell leukemia\/lymphoma","volume":"141","author":"Izutsu","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2025.107680_bib37","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/s41586-024-07103-x","article-title":"Mechanisms of action and resistance in histone methylation-targeted therapy","volume":"627","author":"Yamagishi","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.leukres.2025.107680_bib38","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","article-title":"International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes","volume":"26","author":"Vose","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.leukres.2025.107680_bib39","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1182\/blood-2015-03-632489","article-title":"Treatment and survival among 1594 patients with ATL","volume":"126","author":"Katsuya","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2025.107680_bib40","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/hon.2558","article-title":"The outcome and characteristics of patients with relapsed adult T cell leukemia\/lymphoma after allogeneic hematopoietic stem cell transplantation","volume":"37","author":"Kato","year":"2019","journal-title":"Hematol. Oncol."},{"key":"10.1016\/j.leukres.2025.107680_bib41","doi-asserted-by":"crossref","first-page":"4567","DOI":"10.1111\/cas.14658","article-title":"Prognosis of patients with adult T-cell leukemia\/lymphoma in Japan: A nationwide hospital-based study","volume":"111","author":"Imaizumi","year":"2020","journal-title":"Cancer Sci."},{"key":"10.1016\/j.leukres.2025.107680_bib42","doi-asserted-by":"crossref","first-page":"8461","DOI":"10.1128\/JVI.75.18.8461-8468.2001","article-title":"Examining human T-lymphotropic virus type 1 infection and replication by cell-free infection with recombinant virus vectors","volume":"75","author":"Derse","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.leukres.2025.107680_bib43","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1126\/science.1080115","article-title":"Spread of HTLV-I between lymphocytes by virus-induced polarization of the cytoskeleton","volume":"299","author":"Igakura","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.leukres.2025.107680_bib44","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nm.2065","article-title":"Biofilm-like extracellular viral assemblies mediate HTLV-1 cell-to-cell transmission at virological synapses","volume":"16","author":"Pais-Correia","year":"2010","journal-title":"Nat. Med"},{"key":"10.1016\/j.leukres.2025.107680_bib45","article-title":"M-Sec induced by HTLV-1 mediates an efficient viral transmission","volume":"17","author":"Ronald","year":"2021","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.leukres.2025.107680_bib46","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S0140-6736(87)92358-0","article-title":"Breaking the cycle of HTLV-I transmission via carrier mothers' milk","volume":"18","author":"Hino","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.leukres.2025.107680_bib47","doi-asserted-by":"crossref","first-page":"555","DOI":"10.7326\/0003-4819-111-7-555","article-title":"Sexual transmission of human T-lymphotropic virus type I (HTLV-I)","volume":"111","author":"Murpy","year":"1989","journal-title":"Ann. Intern Med"},{"key":"10.1016\/j.leukres.2025.107680_bib48","doi-asserted-by":"crossref","first-page":"388","DOI":"10.3389\/fmicb.2012.00388","article-title":"Epidemiological aspects and world distribution of HTLV-1 infection","volume":"3","author":"Gessain","year":"2012","journal-title":"Front Microbiol"},{"key":"10.1016\/j.leukres.2025.107680_bib49","doi-asserted-by":"crossref","first-page":"6171","DOI":"10.1172\/JCI135525","article-title":"HTLV-1 targets human placental trophoblasts in seropositive pregnant women","volume":"130","author":"Tezuka","year":"2020","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.leukres.2025.107680_bib50","article-title":"The relative contributions of infectious and mitotic spread to HTLV-1 persistence","volume":"16","author":"Regoes","year":"2020","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.leukres.2025.107680_bib51","doi-asserted-by":"crossref","first-page":"12813","DOI":"10.1128\/JVI.76.24.12813-12822.2002","article-title":"The complementary strand of the human T-cell leukemia virus type 1 RNA genome encodes a bZIP transcription factor that down-regulates viral transcription","volume":"76","author":"Gaudray","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.leukres.2025.107680_bib52","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/348245a0","article-title":"Circulating CD8+\u2009cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease","volume":"348","author":"Jacobson","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.leukres.2025.107680_bib53","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1093\/intimm\/3.8.761","article-title":"Predominant recognition of human T cell leukemia virus type I (HTLV-I) pX gene products by human CD8+\u2009cytotoxic T cells directed against HTLV-l-infected cells","volume":"3","author":"Kannagi","year":"1990","journal-title":"Int Immunol."},{"key":"10.1016\/j.leukres.2025.107680_bib54","doi-asserted-by":"crossref","DOI":"10.1186\/s12977-014-0116-6","article-title":"Cytotoxic T lymphocyte lysis of HTLV-1 infected cells is limited by weak HBZ protein expression, but non-specifically enhanced on induction of Tax expression","volume":"11","author":"Rowan","year":"2014","journal-title":"Retrovirology"},{"key":"10.1016\/j.leukres.2025.107680_bib55","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1001117","article-title":"HLA class I binding of HBZ determines outcome in HTLV-1 infection","volume":"6","author":"MacNamara","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.leukres.2025.107680_bib56","doi-asserted-by":"crossref","DOI":"10.1038\/srep27150","article-title":"Enhancement of anti-STLV-1\/HTLV-1 immune responses through multimodal effects of anti-CCR4 antibody","volume":"6","author":"Sugata","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.leukres.2025.107680_bib57","doi-asserted-by":"crossref","first-page":"4856","DOI":"10.1128\/JVI.73.6.4856-4865.1999","article-title":"Immortalization of CD4+\u2009and CD8+\u2009T lymphocytes by human T-cell leukemia virus type 1 tax mutants expressed in a functional molecular clone","volume":"73","author":"Robek","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.leukres.2025.107680_bib58","doi-asserted-by":"crossref","first-page":"5431","DOI":"10.1128\/JVI.02460-09","article-title":"Induction of reactive oxygen species by human T-cell leukemia virus type 1 tax correlates with DNA damage and expression of cellular senescence marker","volume":"84","author":"Kinjo","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.leukres.2025.107680_bib59","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002025","article-title":"NF-\u03baB hyper-activation by HTLV-1 tax induces cellular senescence, but can be alleviated by the viral anti-sense protein HBZ","volume":"7","author":"Zhi","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.leukres.2025.107680_bib60","doi-asserted-by":"crossref","DOI":"10.12688\/wellcomeopenres.12469.2","article-title":"Single-cell heterogeneity and cell-cycle-related viral gene bursts in the human leukaemia virus HTLV-1","volume":"2","author":"Billman","year":"2017","journal-title":"Wellcome Open Res"},{"key":"10.1016\/j.leukres.2025.107680_bib61","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/j.chembiol.2017.08.016","article-title":"Glucose metabolism and oxygen availability govern reactivation of the latent human retrovirus HTLV-1","volume":"24","author":"Kulkarni","year":"2017","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.leukres.2025.107680_bib62","doi-asserted-by":"crossref","first-page":"E1269","DOI":"10.1073\/pnas.1715724115","article-title":"Sporadic on\/off switching of HTLV-1 Tax expression is crucial to maintain the whole population of virus-induced leukemic cells","volume":"115","author":"Mahgoub","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.leukres.2025.107680_bib63","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2020.00979","article-title":"Strategies of human T-cell leukemia virus type 1 for persistent infection: implications for leukemogenesis of adult T-cell leukemia-lymphoma","volume":"11","author":"Yasunaga","year":"2020","journal-title":"Front Microbiol"},{"key":"10.1016\/j.leukres.2025.107680_bib64","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1182\/blood.V97.4.987","article-title":"Existence of escape mutant in HTLV-I tax during the development of adult T-cell leukemia","volume":"97","author":"Furukawa","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2025.107680_bib65","doi-asserted-by":"crossref","first-page":"7278","DOI":"10.1128\/JVI.02239-09","article-title":"APOBEC3G generates nonsense mutations in human T-cell leukemia virus type 1 proviral genomes in vivo","volume":"84","author":"Fan","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.leukres.2025.107680_bib66","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/ijc.20007","article-title":"Genetic and epigenetic inactivation of tax gene in adult T-cell leukemia cells","volume":"109","author":"Takeda","year":"2004","journal-title":"Int J. Cancer"},{"key":"10.1016\/j.leukres.2025.107680_bib67","doi-asserted-by":"crossref","DOI":"10.1186\/1742-4690-2-64","article-title":"Silencing of human T-cell leukemia virus type I gene transcription by epigenetic mechanisms","volume":"2","author":"Taniguchi","year":"2005","journal-title":"Retrovirology"},{"key":"10.1016\/j.leukres.2025.107680_bib68","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1182\/blood.V88.8.3065.bloodjournal8883065","article-title":"Two types of defective human T-lymphotropic virus type I provirus in adult T-cell leukemia","volume":"88","author":"Tamiya","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2025.107680_bib69","doi-asserted-by":"crossref","first-page":"5714","DOI":"10.1128\/JVI.02511-06","article-title":"Preferential selection of human T-cell leukemia virus type 1 provirus lacking the 5\u2032 long terminal repeat during oncogenesis","volume":"81","author":"Miyazaki","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.leukres.2025.107680_bib70","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.celrep.2019.09.016","article-title":"The nature of the HTLV-1 provirus in naturally infected individuals analyzed by the viral DNA-capture-seq approach","volume":"29","author":"Katsuya","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.leukres.2025.107680_bib71","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2309925121","article-title":"Vulnerability to APOBEC3G linked to the pathogenicity of deltaretroviruses","volume":"121","author":"Shichijo","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.leukres.2025.107680_bib72","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1073\/pnas.0507631103","article-title":"HTLV-I basic leucine zipper factor gene mRNA supports proliferation of adult T cell leukemia cells","volume":"103","author":"Satou","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.leukres.2025.107680_bib73","doi-asserted-by":"crossref","first-page":"9359","DOI":"10.1128\/JVI.00242-08","article-title":"Transcriptional control of spliced and unspliced human T-cell leukemia virus type 1 bZIP factor (HBZ) gene","volume":"82","author":"Yoshida","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.leukres.2025.107680_bib74","doi-asserted-by":"crossref","DOI":"10.1186\/1742-4690-5-34","article-title":"Characteristic expression of HTLV-1 basic zipper factor (HBZ) transcripts in HTLV-1 provirus-positive cells","volume":"5","author":"Usui","year":"2008","journal-title":"Retrovirology"},{"key":"10.1016\/j.leukres.2025.107680_bib75","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1073\/pnas.1423199113","article-title":"The retrovirus HTLV-1 inserts an ectopic CTCF-binding site into the human genome","volume":"113","author":"Satou","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.leukres.2025.107680_bib76","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1038\/s41467-022-30029-9","article-title":"Identification and characterization of a novel enhancer in the HTLV-1 proviral genome","volume":"13","author":"Matsuo","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.leukres.2025.107680_bib77","doi-asserted-by":"crossref","first-page":"4143","DOI":"10.1158\/0008-5472.CAN-15-0942","article-title":"HTLV-1 bZIP Factor RNA and protein impart distinct functions on T-cell proliferation and survival","volume":"75","author":"Mitobe","year":"2015","journal-title":"Cancer Res"},{"key":"10.1016\/j.leukres.2025.107680_bib78","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.875211","article-title":"Functional and pathogenic roles of retroviral antisense transcripts","volume":"13","author":"Toyoda","year":"2022","journal-title":"Front Immunol."},{"key":"10.1016\/j.leukres.2025.107680_bib79","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1158\/2643-3230.BCD-22-0139","article-title":"HTLV-1 bZIP factor-induced reprogramming of lactate metabolism and epigenetic status promote leukemic cell expansion","volume":"4","author":"Toyoda","year":"2023","journal-title":"Blood Cancer Discov."},{"key":"10.1016\/j.leukres.2025.107680_bib80","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003271","article-title":"Genome-wide determinants of proviral targeting, clonal abundance and expression in natural HTLV-1 infection","volume":"9","author":"Melamed","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.leukres.2025.107680_bib81","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1182\/blood-2014-02-553602","article-title":"The role of HTLV-1 clonality, proviral structure, and genomic integration site in adult T-cell leukemia\/lymphoma","volume":"123","author":"Cook","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2025.107680_bib82","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abm6210","article-title":"Selective clonal persistence of human retroviruses in vivo: Radial chromatin organization, integration site, and host transcription","volume":"8","author":"Melamed","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.leukres.2025.107680_bib83","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1365-2141.2004.04999.x","article-title":"Expression of FoxP3, a key molecule in CD4+CD25+\u2009regulatory T cells, in adult T-cell leukaemia\/lymphoma cells","volume":"126","author":"Karube","year":"2004","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.leukres.2025.107680_bib84","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/modpathol.2008.25","article-title":"The relationship of FOXP3 expression and clinicopathological characteristics in adult T-cell leukemia\/lymphoma","volume":"21","author":"Karube","year":"2008","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.leukres.2025.107680_bib85","doi-asserted-by":"crossref","first-page":"5047","DOI":"10.1182\/blood-2007-10-118539","article-title":"High frequency of CD4+FoxP3+\u2009cells in HTLV-1 infection: inverse correlation with HTLV-1\u2013specific CTL response","volume":"111","author":"Toulza","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2025.107680_bib86","article-title":"HTLV-1 modulates the frequency and phenotype of FoxP3+CD4+\u2009T cells in virus-infected individuals","volume":"30","author":"Satou","year":"2012","journal-title":"Retrovirology"},{"key":"10.1016\/j.leukres.2025.107680_bib87","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.4049\/jimmunol.155.3.1151","article-title":"Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases","volume":"155","author":"Sakaguchi","year":"1995","journal-title":"J. Immunol."},{"key":"10.1016\/j.leukres.2025.107680_bib88","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1093\/intimm\/dxh165","article-title":"Crucial role of FOXP3 in the development and function of human CD25+CD4+\u2009regulatory T cells","volume":"16","author":"Yagi","year":"2004","journal-title":"Int Immunol."},{"key":"10.1016\/j.leukres.2025.107680_bib89","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.cell.2008.05.009","article-title":"Regulatory T cells and immune tolerance","volume":"133","author":"Sakaguchi","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.leukres.2025.107680_bib90","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1182\/blood-2010-12-326199","article-title":"HTLV-1 bZIP factor enhances TGF-beta signaling through p300 coactivator","volume":"118","author":"Zhao","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2025.107680_bib91","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1001274","article-title":"HTLV-1 bZIP factor induces T-cell lymphoma and systemic inflammation in vivo","volume":"7","author":"Satou","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.leukres.2025.107680_bib92","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003630","article-title":"HTLV-1 bZIP factor induces inflammation through labile Foxp3 expression","volume":"9","author":"Yamamoto-Taguchi","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.leukres.2025.107680_bib93","article-title":"Interferon-gamma promotes inflammation and development of T-cell lymphoma in HTLV-1 bZIP factor transgenic mice","volume":"11","author":"Mitagami","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.leukres.2025.107680_bib94","doi-asserted-by":"crossref","first-page":"5068","DOI":"10.1158\/0008-5472.CAN-16-0361","article-title":"HTLV-1 viral factor HBZ induces CCR4 to promote T-cell migration and proliferation","volume":"76","author":"Sugata","year":"2016","journal-title":"Cancer Res"},{"key":"10.1016\/j.leukres.2025.107680_bib95","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005372","article-title":"HTLV-1 bZIP factor impairs anti-viral immunity by inducing co-inhibitory molecule, T cell immunoglobulin and ITIM domain (TIGIT)","volume":"12","author":"Yasuma","year":"2016","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.leukres.2025.107680_bib96","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/intimm\/dxh366","article-title":"Regulatory T cell-like activity of Foxp3+\u2009adult T cell leukemia cells","volume":"18","author":"Chen","year":"2006","journal-title":"Int Immunol."},{"key":"10.1016\/j.leukres.2025.107680_bib97","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/j.1349-7006.2007.00646.x","article-title":"Adult T-cell leukemia\/lymphoma cells from blood and skin tumors express cytotoxic T lymphocyte-associated antigen-4 and Foxp3 but lack suppressor activity toward autologous CD8+\u2009T cells","volume":"99","author":"Shimauchi","year":"2007","journal-title":"Cancer Sci."},{"key":"10.1016\/j.leukres.2025.107680_bib98","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1002\/ijc.24664","article-title":"FoxP3+\u2009regulatory T cells are distinct from leukemia cells in HTLV-1\u2013associated adult T-cell leukemia","volume":"125","author":"Toulza","year":"2009","journal-title":"Int J. Cancer"},{"key":"10.1016\/j.leukres.2025.107680_bib99","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1182\/blood-2011-05-357459","article-title":"HTLV-1 bZIP factor impairs cell-mediated immunity by suppressing production of Th1 cytokines","volume":"119","author":"Sugata","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2025.107680_bib100","article-title":"HTLV-1 bZIP Factor enhances T-cell proliferation by impeding the suppressive signaling of co-inhibitory receptors","volume":"13","author":"Kinosada","year":"2017","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.leukres.2025.107680_bib101","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/s41375-020-0788-y","article-title":"Ectonucleotidase CD39 is highly expressed on ATLL cells and is responsible for their immunosuppressive function","volume":"35","author":"Nagate","year":"2020","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2025.107680_bib102","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1158\/2643-3230.BCD-21-0044","article-title":"Single-cell analysis of the multicellular ecosystem in viral carcinogenesis by HTLV-1","volume":"2","author":"Koya","year":"2021","journal-title":"Blood Cancer Discov."},{"key":"10.1016\/j.leukres.2025.107680_bib103","doi-asserted-by":"crossref","DOI":"10.1172\/JCI150472","article-title":"HTLV-1 infection promotes excessive T cell activation and transformation into adult T cell leukemia\/lymphoma","author":"Tan","year":"2021","journal-title":"J. Clin. Invest. 131"},{"key":"10.1016\/j.leukres.2025.107680_bib104","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.991928","article-title":"HTLV-1 persistence and leukemogenesis: A game of hide-and-seek with the host immune system","volume":"13","author":"Tan","year":"2022","journal-title":"Front Immunol."},{"key":"10.1016\/j.leukres.2025.107680_bib105","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1182\/blood.2022015646","article-title":"Genome-wide CRISPR screens identify CD48 defining susceptibility to NK cytotoxicity in peripheral T-cell lymphomas","volume":"140","author":"Chiba","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2025.107680_bib106","doi-asserted-by":"crossref","DOI":"10.1186\/s12977-015-0236-7","article-title":"Rapid dissemination of human T-lymphotropic virus type 1 during primary infection in transplant recipients","volume":"13","author":"Cook","year":"2016","journal-title":"Retrovirology"},{"key":"10.1016\/j.leukres.2025.107680_bib107","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009271","article-title":"In vivo dynamics and adaptation of HTLV-1-infected clones under different clinical conditions","volume":"17","author":"Izaki","year":"2021","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.leukres.2025.107680_bib108","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.ccell.2018.06.014","article-title":"Targeting the HTLV-I-regulated BATF3\/IRF4 transcriptional network in adult T cell leukemia\/lymphoma","volume":"34","author":"Nakagawa","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.leukres.2025.107680_bib109","doi-asserted-by":"crossref","first-page":"3788","DOI":"10.1182\/blood-2008-04-154286","article-title":"Human T-cell leukemia virus type-1 antisense-encoded gene, Hbz, promotes T-lymphocyte proliferation","volume":"112","author":"Arnold","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2025.107680_bib110","doi-asserted-by":"crossref","first-page":"4222","DOI":"10.1038\/onc.2012.450","article-title":"HTLV-1 bZIP factor dysregulates the Wnt pathways to support proliferation and migration of adult T-cell leukemia cells","volume":"32","author":"Ma","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.leukres.2025.107680_bib111","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2014783118","article-title":"Human retroviral antisense mRNAs are retained in the nuclei of infected cells for viral persistence","volume":"118","author":"Ma","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.leukres.2025.107680_bib112","doi-asserted-by":"crossref","first-page":"4509","DOI":"10.1038\/onc.2015.510","article-title":"HTLV-1 bZIP factor protein targets the Rb\/E2F-1 pathway to promote proliferation and apoptosis of primary CD4+\u2009T cells","volume":"35","author":"Kawatsuki","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.leukres.2025.107680_bib113","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1158\/0008-5472.CAN-13-0436","article-title":"HTLV-1 bZIP factor suppresses apoptosis by attenuating the function of FoxO3a and altering its localization","volume":"74","author":"Tanaka-Nakanishi","year":"2014","journal-title":"Cancer Res"},{"key":"10.1016\/j.leukres.2025.107680_bib114","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006722","article-title":"Human T-cell leukemia virus type 1 infects multiple lineage hematopoietic cells in vivo","volume":"13","author":"Furuta","year":"2017","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.leukres.2025.107680_bib115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006597","article-title":"IL-10-mediated signals act as a switch for lymphoproliferation in human T-cell leukemia virus type-1 infection by activating the STAT3 and IRF4 pathways","volume":"13","author":"Sawada","year":"2017","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.leukres.2025.107680_bib116","doi-asserted-by":"crossref","first-page":"13740","DOI":"10.1073\/pnas.1922884117","article-title":"HTLV-1 induces T cell malignancy and inflammation by viral antisense factor-mediated modulation of the cytokine signaling","volume":"117","author":"Higuchi","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.leukres.2025.107680_bib117","doi-asserted-by":"crossref","first-page":"4821","DOI":"10.1038\/s41467-021-25101-9","article-title":"Chronological genome and single-cell transcriptome integration characterizes the evolutionary process of adult T cell leukemia-lymphoma","volume":"12","author":"Yamagishi","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.leukres.2025.107680_bib118","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1038\/ng.3415","article-title":"Integrated molecular analysis of adult T cell leukemia\/lymphoma","volume":"47","author":"Kataoka","year":"2015","journal-title":"Nat. Genet"},{"key":"10.1016\/j.leukres.2025.107680_bib119","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.18632\/oncotarget.6424","article-title":"Human T-cell leukemia virus type-1-encoded protein HBZ represses p53 function by inhibiting the acetyltransferase activity of p300\/CBP and HBO1","volume":"7","author":"Wright","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.leukres.2025.107680_bib120","doi-asserted-by":"crossref","first-page":"23903","DOI":"10.1074\/jbc.M803116200","article-title":"An interaction between the human T cell leukemia virus type 1 basic leucine zipper factor (HBZ) and the KIX domain of p300\/CBP contributes to the down-regulation of Tax-dependent viral transcription by HBZ","volume":"283","author":"Clerc","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.leukres.2025.107680_bib121","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/nature18294","article-title":"Aberrant PD-L1 expression through 3\u2032-UTR disruption in multiple cancers","volume":"534","author":"Kataoka","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.leukres.2025.107680_bib122","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1182\/blood.2021013568","article-title":"Whole-genome landscape of adult T-cell leukemia\/lymphoma","volume":"139","author":"Kogure","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2025.107680_bib123","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1182\/blood.2019002665","article-title":"Evolution of retrovirus-infected premalignant T-cell clones prior to adult T-cell leukemia\/lymphoma diagnosis","volume":"135","author":"Rowan","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2025.107680_bib124","doi-asserted-by":"crossref","DOI":"10.1038\/s41408-021-00458-8","article-title":"Quantification of T cell clonality in human T cell leukaemia virus type-1 carriers can detect the development of adult T cell leukaemia early","volume":"11","author":"Wolf","year":"2021","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.leukres.2025.107680_bib125","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/cas.15997","article-title":"Anti-HTLV-1 immunity combined with proviral load as predictive biomarkers for adult T-cell leukemia-lymphoma","volume":"115","author":"Yamada","year":"2024","journal-title":"Cancer Sci."},{"key":"10.1016\/j.leukres.2025.107680_bib126","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1111\/cas.13398","article-title":"Epidemiological and clinical features of adult T-cell leukemia-lymphoma in Japan, 2010-2011: A nationwide survey","volume":"108","author":"Nosaka","year":"2017","journal-title":"Cancer Sci."},{"key":"10.1016\/j.leukres.2025.107680_bib127","doi-asserted-by":"crossref","first-page":"3488","DOI":"10.1182\/blood-2012-07-445593","article-title":"HTLV-1\u2013infected T cells contain a single integrated provirus in natural infection","volume":"120","author":"Cook","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2025.107680_bib128","first-page":"4862","article-title":"Persistent clonal proliferation of human T-lymphotropic virus type I-infected cells in vivo","volume":"57","author":"Etoh","year":"1997","journal-title":"Cancer Res"},{"key":"10.1016\/j.leukres.2025.107680_bib129","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1182\/blood-2010-10-312926","article-title":"The host genomic environment of the provirus determines the abundance of HTLV-1-infected T-cell clones","volume":"117","author":"Gillet","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2025.107680_bib130","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1182\/blood-2009-12-257410","article-title":"Human T-cell leukemia virus type I (HTLV-1) proviral load and disease progression in asymptomatic HTLV-1 carriers: a nationwide prospective study in Japan","volume":"116","author":"Iwanaga","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2025.107680_bib131","first-page":"1043","article-title":"Increasing methylation of the CDKN2A gene is associated with the progression of adult T-cell leukemia","volume":"60","author":"Nosaka","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.leukres.2025.107680_bib132","doi-asserted-by":"crossref","first-page":"6002","DOI":"10.1158\/0008-5472.CAN-04-1422","article-title":"Identification of aberrantly methylated genes in association with adult T-cell leukemia","volume":"64","author":"Yasunaga","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.leukres.2025.107680_bib133","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1182\/blood-2003-07-2482","article-title":"Aberrant expression of the MEL1S gene identified in association with hypomethylation in adult T-cell leukemia cells","volume":"103","author":"Yoshida","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2025.107680_bib134","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ccr.2011.12.015","article-title":"Polycomb-mediated loss of miR-31 activates NIK-dependent NF-\u03baB pathway in adult T cell leukemia and other cancers","volume":"21","author":"Yamagishi","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.leukres.2025.107680_bib135","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1182\/blood-2015-08-662593","article-title":"Polycomb-dependent epigenetic landscape in adult T-cell leukemia","volume":"127","author":"Fujikawa","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2025.107680_bib136","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1182\/blood-2016-09-692574","article-title":"Adult T-cell leukemia: molecular basis for clonal expansion and transformation of HTLV-1\u2013infected T cells","volume":"129","author":"Watanabe","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2025.107680_bib137","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1182\/blood.2019003084","article-title":"Targeting aberrant DNA hypermethylation as a driver of ATL leukemogenesis by using the new oral demethylating agent OR-2100","volume":"136","author":"Watanabe","year":"2020","journal-title":"Blood"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212625000402?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212625000402?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T18:43:41Z","timestamp":1777488221000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212625000402"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":137,"alternative-id":["S0145212625000402"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2025.107680","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stratagems of HTLV-1 for persistent infection and the resultant oncogenesis: Immune evasion and clonal expansion","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2025.107680","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107680"}}